Drug Shortage Report for NEXIUM - 20MG

Last updated on 2021-02-18 History
Report ID 131188
Drug Identification Number 02244521
Brand name NEXIUM - 20MG
Common or Proper name esomeprazole
Company Name ASTRAZENECA CANADA INC
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 20MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 28 tablets
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-02-16
Actual start date 2021-02-16
Estimated end date 2021-02-18
Actual end date 2021-02-17
Shortage status Resolved
Updated date 2021-02-18
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-02-18 French Compare
v8 2021-02-18 English Compare
v7 2021-02-17 English Compare
v6 2021-02-16 French Compare
v5 2021-02-16 English Compare
v4 2021-01-26 French Compare
v3 2021-01-26 English Compare
v2 2021-01-08 French Compare
v1 2021-01-08 English Compare

Showing 1 to 9 of 9